ESC 22: Hot Line & Late-breaking Science Video Collection

Published: 24 August 2022

  • Views:

    Views Icon 6349

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

What's hot at European Society of Cardiology (ESC) Congress 22?

Stay tuned and browse our curated coverage of the latest data in cardiology. 

  • For a concise line up of the most awaited trials join Prof Nicolas Van Mieghem and Dr Joost Daemen and their regular View From the Thoraxcenter series. 
  • For a deeper dive into key clinical trial data and applicability, host, Dr Harriette Van Spall talks with principal investigators in her Late-Breaker Discussion Series. 
  • Short, accessible Expert Interviews conducted with select faculty focusing on data, patient care and the future of their field. 
  • To mark the release of the new ESC Guidelines on Cardio-Oncology, we will feature a 10-minute summary and a 10-minute live audience Q&A.
  • We asked some of the most prominent researchers today about their pathways in the Behind the Heart series.

Watch our Radcliffe Premiere TV to be transported to Barcelona. 

More from this programme

Part 1

View From the Thoraxcenter: Review Series

In this short and engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most impactful hot-line and late-breaking trials from ESC 2022. Which trials should we look out for?
2 sessions
View from the Thoraxcenter – ESC 2022 Wrap Up Watch now
View from the Thoraxcenter – ESC 2022 Preview Watch now

Part 2

Late-breaker Discussion Series With Dr Harriette Van Spall

The Late-breaker discussion series will spotlight some of the most awaited hot line trials from this year's ESC. Stay tuned.
4 sessions
Late-breaker Discussion: The INVICTUS Trial Watch now
Late-breaker Discussion: The DELIVER Trial Watch now
Late-breaker Discussion: The REVIVED Trial Watch now
Late-breaker Discussion: The ADVOR Trial Watch now

Part 3

ESC Guidelines on Cardio-Oncology: Summary & Question Time

In the first part of the programme chairs of the new ESC Guidelines on Cardio-Oncology, Dr Alexander Lyon and Dr Teresa López-Fernández summarised the key take-home messages.In the second part they answered questions coming from the audience with the moderation of Dr Arjun Ghosh.
1 session
ESC 22 Guidelines on Cardio-Oncology: Summary & Question Time Watch now

Part 4

Hot Line & Late-breaking Interviews

In this series, we will interview the presenters of 20 hot line and late-breaking trials to give you a quick updated on the hottest data in cardiology.
17 sessions
ASCEND: Aspirin and Omega-3 Fatty Acids in Preventing Heart Failure Watch now
ALL-HEART: Allopurionol in the Treatment of Ischaemic Heart Disease Watch now
PACIFIC-STROKE: Dosing of Asundexian in Pts With Non-Cardioembolic Ischemic Stroke Watch now
PACIFIC-AMI: Asundexian on Top of DAPT After Acute Myocardial Infarction Watch now
ADVENT-HF: Adaptive Servo Ventilation in Patients with Heart Failure and Sleep Apnea Watch now
AXIOMATIC-SSP: Milvexian in Additon to Aspirin and Clopidogrel for Secondary Stroke Prevention Watch now
Artificial Intelligence Detection of Severe Aortic Stenosis Watch now
MOMENTUM 3: 5-year Results From HeartMate 3 LVAD Therapy Watch now
MASTER DAPT Results at 15M with Prof Valgimigli Watch now
APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID Watch now
The PRE18FFIR Trial: 18F-NaF PET for Vulnerable Coronary Plaque imaging After MI Watch now
FIDELITY: Finerenone in Pts With Chronic Kidney Disease Watch now
The EMPEROR-POOLED Trial: Clinical Benefits of SGLT2i in Heart Failure Watch now
The EMMY Trial: Empagliflozin in Patients with Acute MI Watch now
COVID-PACT: Antithrombotic Therapy in Critically Ill COVID-19 Pts Watch now
ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19 Watch now
PERSPECTIVE: Sacubitril/Valsartan & Cognitive Function in HFmrEF & HFpEF Watch now

Part 5

Behind the Heart from Barcelona

Personal voices in the cardiovascular community.
19 sessions
Behind the Heart: Michelle Goonasekera Watch now
Behind the Heart: Isla S Mackenzie Watch now
Behind the Heart: Douglas Bradley Watch now
Behind the Heart: Ashkan Shoamanesh Watch now
Behind the Heart: Mukul Sharma Watch now
Behind the Heart: Geoffrey Strange Watch now
Behind the Heart: Martha Gulati Watch now
Behind the Heart: John H Alexander Watch now
Behind the Heart: Renato D Lopes Watch now
Behind the Heart: David Newby Watch now
Behind the Heart: Faiez Zannad Watch now
Behind the Heart: Harald Sourij Watch now
Behind the Heart: David Berg Watch now
Behind the Heart: Sanjit Jolly Watch now
Behind the Heart: Mirvat Alasnag Watch now
Behind the Heart: Martha Gulati Watch now
Behind the Heart: Purvi Parwani Watch now
Behind the Heart: John McMurray Watch now
Behind the Heart: Marco Valgimigli Watch now

Part 6

3 Trials That Will Change Your Practice: Reviews

4 sessions
REVIVED-BCIS2, RTC, FRAME-AMI by Dr Mirvat Alasnag Watch now
DANCAVAS, DELIVER, SECURE by Dr Purvi Parwani Watch now
eBRAVE-AF, CAPLA, INVICTUS by Dr Afzal Sohaib Watch now
TIME, SECURE, DANCAVAS by Dr Martha Gulati Watch now

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Medical Director

Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

His current research focuses on cerebral embolic protection during TAVI and the search for improved…

View full profile
Joost Daemen

Joost Daemen

Interventional Cardiologist

Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile